Table 1.
Genotyping Results Using Different Assays
Patient | Subtype by Lipa/ Trugene or Abbott RT-PCR Assay | Amplicon Deep Sequencing | Full-Genome Sequencing | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NS3 | NS5A | NS5B | Subtype | Nt Homology, % | |||||||||||
nt | H omology, % | aa | Homology, % | nt | Homology, % | aa | Homology, % | nt | Homology, % | aa | Homology, % | ||||
1 | 2a/2c | ND | NA | ND | NA | 2j | 79 | 2i | 84 | 2e | 86 | 2d | 92 | Novel GT2 subtype | 82 (2c, 2r, 2d, 2) |
2 | 2a/2c | ND | NA | ND | NA | 2d | 79 | 2j | 85 | 2e | 86 | 2k | 91 | Novel GT2 subtype | 82 (2) |
3 | 2 | ND | NA | ND | NA | 2e | 82 | 2j | 86 | 2e | 88 | 2e | 94 | Novel GT2 subtype | 85 (2) |
4 | 2 | 2a | 82 | 2c | 92 | 2q | 78 | 2j | 80 | 2e | 83 | 2d | 89 | Novel GT2 subtype | 82 (2) |
5 | 2a/2c | 2q | 86 | 2c | 96 | 2q | 81 | 2k | 86 | 2k | 88 | 2k | 93 | Novel GT2 subtype | 84 (2k, 2q) |
6 | 2a/2c | 2a | 81 | 2c | 94 | 2a | 79 | 2a | 83 | 2a | 86 | 2a | 92 | Novel GT2 subtype | 82 (2a, 2) |
7 | 2b/2j | 2i | 75 | 2j | 87 | No hit | 0 | 2i | 77 | 2r | 80 | 2r | 86 | Novel GT2 subtype | 83 (2l) |
8 | 2l | 2e | 75 | 2i | 89 | No hit | 0 | 2b | 75 | 2r | 79 | 2r | 85 | Novel GT2 subtype | 81 (2l) |
9 | 2 | ND | NA | ND | NA | 2d | 80 | 2e | 85 | 2k | 86 | 2d | 92 | Novel GT2 subtype | 83 (2c, 2q) |
10 | 4 | 4a | 83 | 4a | 94 | 4v | 79 | 4v | 85 | 4l | 87 | 4l | 92 | Novel GT4 subtype | 82 (4v, 4l) |
11 | 4a/4c | 4a | 88 | 4a | 97 | 4a | 86 | 4a | 92 | 4c | 91 | 4c | 96 | Novel GT4 subtype | 86 (4a, 4) |
12 | 4l/4t | 4t | 83 | 4t | 94 | 4a | 79 | 4t | 85 | 4p | 87 | 4l | 93 | Novel GT4 subtype | 84 (4p) |
13 | 4m/4v | 4o | 82 | 4v | 95 | 4v | 79 | 4a | 85 | 4l | 86 | 4m | 93 | Novel GT4 subtype | 82 (4v, 4q, 4l, 4) |
14 | 4a/4c | 4c | 84 | ND | ND | 4v | 81 | ND | ND | ND | ND | 4a | 89 | Novel GT4 subtype | 84 (4) |
15 | 6c/6q | 6d | 78 | 6c | 94 | 6p | 75 | 6q | 87 | 6q | 86 | 6q | 92 | Novel GT6 subtype | 84 (6q) |
16 | 1b | ND | ND | ND | ND | 6w | 72 | 6g | 84 | No hit | 0 | 6g | 88 | Novel GT6 subtype | 80 (6q) |
17 | 1b | 1a | 79 | 1h | 91 | 1c | 78 | 1c | 84 | 1c | 86 | 1c | 92 | Novel GT1 subtype | 81 (1c, 1) |
18 | 3f | NA | NA | NA | NA | 3i | 79 | 3g | 87 | 3i | 87 | 3i | 94 | Novel GT3 subtype | 82 (3i) |
19 | 5a | NA | NA | NA | NA | 1b | 74 | 5a | 84 | 4v | 71 | 5a | 85 | Novel GT5 subtype | 78 (5a) |
Homology, in percentage, was calculated by BLASTN analysis for NS3, NS5A, and NS5B. The subtype with the highest match is shown. BLASTN was performed on the sequences generated by full–HCV genome sequencing; the query nucleotide length was 6567 for GT2, 9334 for GT3, 6576 for GT4, 4098 for GT6, 7270 for GT1, and 4095 for GT5.
Abbreviations: aa, amino acid; GT, genotype; HCV, hepatitis C virus; nt, nucleotide; RT-PCR, reverse transcriptase polymerase chain reaction.